REAL-WORLD ADHERENCE TO SINGLE-INHALER VS MULTIPLE-INHALER TRIPLE THERAPY AMONG PATIENTS WITH COPD IN A COMMERCIALLY INSURED US POPULATION

被引:11
|
作者
Bogart, Michael
Wu, Benjamin
Germain, Guillaume
Laliberte, Francois
MacKnight, Sean
Jung, Young
Duh, Mei
机构
关键词
D O I
10.1016/j.chest.2020.08.1548
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1773A / 1774A
页数:2
相关论文
共 50 条
  • [31] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
    Strange, Charlie
    Tkacz, Joseph
    Schinkel, Jill
    Lewing, Benjamin
    Agatep, Barnabie
    Swisher, Sean
    Patel, Sushma
    Edwards, Devechio
    Touchette, Daniel R.
    Portillo, Edward
    Feigler, Norbert
    Pollack, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2245 - 2256
  • [32] Economic impact of delayed multiple-inhaler triple therapy initiation in COPD patients
    Ismaila, Afisi
    Wood, Robert
    Anley, Glenn
    Nam, Yein
    Bluff, Daniel
    Sansbury, Leah
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [33] Once-Daily Single-Inhaler Versus Twice-Daily Multiple-Inhaler Triple Therapy: Two Replicate Trials in Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Ferguson, G. T.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Fogarty, C. M.
    Harvey, C.
    Kaisermann, M. C.
    Lipson, D. A.
    Martin, N.
    Sciurba, F. C.
    Stiegler, M. A.
    Zhu, C.
    Bernstein, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]
    Strange, C.
    Tkacz, J.
    Schinkel, J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1799 - 1799
  • [35] Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy: two replicate trials in patients with chronic obstructive pulmonary disease (COPD)
    Ferguson, G. T.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Fogarty, C.
    Harvey, C.
    Kaisermann, M. C.
    Lipson, D. A.
    Martin, N.
    Sciurba, F.
    Stiegler, M.
    Zhu, C. Q.
    Bernstein, D.
    PNEUMOLOGIE, 2021, 75 : S45 - S46
  • [36] Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data
    Young, Corinne
    Lee, Lydia Y.
    Dirocco, Kristi K.
    Germain, Guillaume
    Klimek, Jacob
    Laliberte, Francois
    Lejeune, Dominique
    Noorduyn, Stephen G.
    Paczkowski, Rosirene
    ADVANCES IN THERAPY, 2025, 42 (02) : 830 - 848
  • [37] Trioptimize VI: The Use of Extrafine Single Inhaler Triple Therapy Improves Adherence to Treatment in Patients with COPD - Real-World Evidence
    Hoevelmann, R.
    Georges, G.
    Javan, S. Bahari
    Melchior, K.
    Criee, C.
    Gessner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [38] Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
    Halpin, David M. G.
    Birk, Ruby
    Brealey, Noushin
    Criner, Gerard J.
    Dransfield, Mark T.
    Hilton, Emma
    Lomas, David A.
    Zhu, Chang-Qing
    Lipson, David A.
    ERJ OPEN RESEARCH, 2018, 4 (02)
  • [39] Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice
    Sansbury, Leah B.
    Bains, Chanchal
    Lipson, David A.
    Ismaila, Afisi S.
    Landis, Sarah H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1255 - 1264
  • [40] Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice
    Lassan, S.
    Keszegh, J.
    Lassanova, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (01): : 27 - 36